Selected research
Industry Research
Allergy Vaccine Industry Research Report 2026
Market perspective
The global Allergy Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Allergy Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Allergy Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Allergy Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Allergy Vaccine include ALK-Abello, Allergy Therapeutics, HAL, Holister Stier, Leti, Stallergenes Greer, WOLW Pharma and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Allergy Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Allergy Vaccine Market by Company
ALK-Abello
Allergy Therapeutics
HAL
Holister Stier
Leti
Stallergenes Greer
WOLW Pharma
Merck
Allergy Vaccine Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergy Vaccine Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
Allergy Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Allergy Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Allergy Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Allergy Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Allergy Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
Applications
- Allergic Rhinitis
- Allergic Asthma
- Other
Companies covered
- ALK-Abello
- Allergy Therapeutics
- HAL
- Holister Stier
- Leti
- Stallergenes Greer
- WOLW Pharma
- Merck
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Allergy Vaccine Market Size (2021-2032)
- 2.2.2 Global Allergy Vaccine Sales (2021-2032)
- 2.2.3 Global Allergy Vaccine Market Average Price (2021-2032)
- 2.3 Allergy Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Subcutaneous Immunotherapy
- 2.3.3 Sublingual Immunotherapy
- 2.4 Allergy Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Allergic Rhinitis
- 2.4.3 Allergic Asthma
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Allergy Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Allergy Vaccine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Allergy Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Allergy Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Allergy Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Allergy Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Allergy Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Allergy Vaccine, Established Date
- 3.9 Global Allergy Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ALK-Abello
- 4.1.1 ALK-Abello Company Information
- 4.1.2 ALK-Abello Business Overview
- 4.1.3 ALK-Abello Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 ALK-Abello Allergy Vaccine Product Portfolio
- 4.1.5 ALK-Abello Recent Developments
- 4.2 Allergy Therapeutics
- 4.2.1 Allergy Therapeutics Company Information
- 4.2.2 Allergy Therapeutics Business Overview
- 4.2.3 Allergy Therapeutics Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Allergy Therapeutics Allergy Vaccine Product Portfolio
- 4.2.5 Allergy Therapeutics Recent Developments
- 4.3 HAL
- 4.3.1 HAL Company Information
- 4.3.2 HAL Business Overview
- 4.3.3 HAL Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 HAL Allergy Vaccine Product Portfolio
- 4.3.5 HAL Recent Developments
- 4.4 Holister Stier
- 4.4.1 Holister Stier Company Information
- 4.4.2 Holister Stier Business Overview
- 4.4.3 Holister Stier Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Holister Stier Allergy Vaccine Product Portfolio
- 4.4.5 Holister Stier Recent Developments
- 4.5 Leti
- 4.5.1 Leti Company Information
- 4.5.2 Leti Business Overview
- 4.5.3 Leti Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Leti Allergy Vaccine Product Portfolio
- 4.5.5 Leti Recent Developments
- 4.6 Stallergenes Greer
- 4.6.1 Stallergenes Greer Company Information
- 4.6.2 Stallergenes Greer Business Overview
- 4.6.3 Stallergenes Greer Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Stallergenes Greer Allergy Vaccine Product Portfolio
- 4.6.5 Stallergenes Greer Recent Developments
- 4.7 WOLW Pharma
- 4.7.1 WOLW Pharma Company Information
- 4.7.2 WOLW Pharma Business Overview
- 4.7.3 WOLW Pharma Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 WOLW Pharma Allergy Vaccine Product Portfolio
- 4.7.5 WOLW Pharma Recent Developments
- 4.8 Merck
- 4.8.1 Merck Company Information
- 4.8.2 Merck Business Overview
- 4.8.3 Merck Allergy Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Merck Allergy Vaccine Product Portfolio
- 4.8.5 Merck Recent Developments
5 Global Allergy Vaccine Market Scenario by Region
- 5.1 Global Allergy Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Allergy Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Allergy Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Allergy Vaccine Sales by Region: 2027-2032
- 5.3 Global Allergy Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Allergy Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Allergy Vaccine Revenue by Region: 2027-2032
- 5.4 North America Allergy Vaccine Market Facts & Figures by Country
- 5.4.1 North America Allergy Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Allergy Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Allergy Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Allergy Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Allergy Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Allergy Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Allergy Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Allergy Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Allergy Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Allergy Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Allergy Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Allergy Vaccine Market Facts & Figures by Country
- 5.7.1 South America Allergy Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Allergy Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Allergy Vaccine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Allergy Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Allergy Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Allergy Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Allergy Vaccine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Allergy Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Allergy Vaccine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Allergy Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Allergy Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Allergy Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Allergy Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Allergy Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Allergy Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Allergy Vaccine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Allergy Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Allergy Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Allergy Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Allergy Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Allergy Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Allergy Vaccine Value Chain Analysis
- 8.1.1 Allergy Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Allergy Vaccine Production Mode & Process
- 8.2 Allergy Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Allergy Vaccine Distributors
- 8.2.3 Allergy Vaccine Customers
9 Global Allergy Vaccine Analyzing Market Dynamics
- 9.1 Allergy Vaccine Industry Trends
- 9.2 Allergy Vaccine Industry Drivers
- 9.3 Allergy Vaccine Industry Opportunities and Challenges
- 9.4 Allergy Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst